Selected article for: "additional measure and prevention control"

Author: Jianghong An; Xuejiao Liao; Tongyang Xiao; Shen Qian; Jing Yuan; Haocheng Ye; Furong Qi; Chengguang Shen; Yang Liu; Lifei Wang; Xiaoya Cheng; Na Li; Qingxian Cai; Fang Wang; Jun Chen; Yingxia Liu; Yunfang Wang; Feng Zhang; Yang Fu; Xiaohua Tan; Lei Liu; Zheng Zhang
Title: Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test
  • Document date: 2020_3_30
  • ID: 58sc6xgq_51
    Snippet: Second, additional studies should measure the dynamic changes of serum specific antibody levels in RP patients and evaluate the continuous protective effect of serum specific antibodies on patients with COVID-19. Finally, we should differentiate RP patients from relapse ones from convalescent subjects, for who two distinct prevention and control strategies will be adopted......
    Document: Second, additional studies should measure the dynamic changes of serum specific antibody levels in RP patients and evaluate the continuous protective effect of serum specific antibodies on patients with COVID-19. Finally, we should differentiate RP patients from relapse ones from convalescent subjects, for who two distinct prevention and control strategies will be adopted.

    Search related documents:
    Co phrase search for related documents
    • additional study and protective effect: 1, 2, 3, 4
    • additional study and specific antibody: 1, 2, 3, 4
    • antibody level and dynamic change: 1, 2, 3
    • antibody level and protective effect: 1, 2, 3, 4
    • antibody level and specific antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
    • control distinct prevention and distinct prevention: 1
    • dynamic change and specific antibody: 1, 2, 3
    • patient specific antibody and specific antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • protective effect and rp patient: 1
    • protective effect and specific antibody: 1, 2, 3, 4, 5, 6
    • relapse one and specific antibody: 1
    • rp patient and specific antibody: 1